Does LANREOTIDE Cause Malignant neoplasm progression? 295 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 295 reports of Malignant neoplasm progression have been filed in association with LANREOTIDE (Lanreotide Acetate). This represents 3.3% of all adverse event reports for LANREOTIDE.
295
Reports of Malignant neoplasm progression with LANREOTIDE
3.3%
of all LANREOTIDE reports
70
Deaths
135
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LANREOTIDE?
Of the 295 reports, 70 (23.7%) resulted in death, 135 (45.8%) required hospitalization, and 15 (5.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANREOTIDE. However, 295 reports have been filed with the FAERS database.
What Other Side Effects Does LANREOTIDE Cause?
Diarrhoea (1,646)
Off label use (1,536)
Death (1,177)
Fatigue (1,022)
Nausea (775)
Abdominal pain (662)
Injection site pain (618)
Malaise (520)
Headache (515)
Asthenia (483)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LANREOTIDE Alternatives Have Lower Malignant neoplasm progression Risk?
LANREOTIDE vs LANSOPRAZOLE
LANREOTIDE vs LANTHANUM
LANREOTIDE vs LANTUS
LANREOTIDE vs LANTUS SOLOSTAR
LANREOTIDE vs LAPATINIB